Clinical features and outcomes of influenza and RSV coinfections: a report from Canadian immunization research network serious outcomes surveillance network.

Journal Information

Full Title: BMC Infect Dis

Abbreviation: BMC Infect Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateAll participants provided informed consent for data, sample collection, and medical record screening per the local Research Ethics Boards’ requirements. The Research Ethics Boards approved the protocol of participating institutions (ClinicalTrials.gov Identifier: NCT01517191). Consent for publicationNot applicable. Competing interestsHP reports grant funding from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) - Finance Code 001. TFH reports grants from Pfizer and GSK, outside the submitted work. SAM reports grants and payments from Pfizer, GSK, Merck, Novartis and Sanofi, outside the submitted work. MK Andrew reports grant funding from the GSK group of companies, Pfizer and Sanofi Pasteur and honoraria for past ad-hoc advisory activities from Pfizer, Sanofi and Seqirus, all unrelated to the present manuscript. JL and ME report no conflicts of interest. Competing interests HP reports grant funding from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) - Finance Code 001. TFH reports grants from Pfizer and GSK, outside the submitted work. SAM reports grants and payments from Pfizer, GSK, Merck, Novartis and Sanofi, outside the submitted work. MK Andrew reports grant funding from the GSK group of companies, Pfizer and Sanofi Pasteur and honoraria for past ad-hoc advisory activities from Pfizer, Sanofi and Seqirus, all unrelated to the present manuscript. JL and ME report no conflicts of interest."

Evidence found in paper:

"Funding Funding for this study was provided by the Public Health Agency of Canada and the Canadian Institutes of Health Research to the Canadian Immunization Research Network and during some seasons through an investigator-initiated Collaborative Research Agreement with GlaxoSmithKline Biologicals SA. Additional funding was obtained through a grant from the Foundation for Influenza Epidemiology under the auspices of the Fondation de France. The authors are solely responsible for the final content and interpretation. The authors received no financial support or other forms of compensation related to the development of the manuscript, and the funders were not involved in analyses, interpretation of findings, or manuscript writing."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025